Davide Catucci
University of Pavia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Davide Catucci.
Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2012
Ciro Esposito; Massimo Torreggiani; Marta Arazzi; Nicoletta Serpieri; Maria Lucia Scaramuzzi; Alessandra Manini; Fabrizio Grosjean; Vittoria Esposito; Davide Catucci; Edoardo La Porta; Antonio Dal Canton
BACKGROUND Nowadays it seems that chronic kidney disease (CKD) is outbreaking, mostly in the elderly participants. The aim of this study was to assess the progression of CKD in different ages. METHODS We conducted a monocentric, retrospective, observational study enrolling 116 patients afferent to our outpatient clinic. INCLUSION CRITERIA age >18 years, follow-up ≥5 years, estimated glomerular filtration rate (eGFR) <60mL/min/1.73 m(2), and/or diagnosed renal disease and/or presence of renal damage. Patients were divided into four groups according to their age: 25-55 years (n = 27), 56-65 (25), 66-75 (42), and 76-87 (22). eGFR was calculated using the modification of diet in renal disease and the CKD-epidemiology collaboration formulas. RESULTS Younger patients had a significantly longer follow-up and less comorbidities, evaluated by the cumulative illness rating scale score, compared with the other groups. There was no difference between creatinine at baseline and at the end-of-follow-up period among the groups. Even though renal function significantly decreased in all groups, we noticed a slower progression as the age increased, and the difference between basal and end-of-follow-up eGFR was minimal in the group of patients aged 76-87 years. Analyzing the eGFR of every ambulatory control plotted against the year of follow-up, we showed a more rapid loss of filtrate in the younger group. Instead, loss of renal function decreased as the age of patients increased. CONCLUSIONS This study demonstrates that, in elderly Italian participants, progression of CKD occurs more slowly than in younger patients. This implies that we may probably face an epidemic of CKD but that most of elderly patients diagnosed with CKD may not evolve to end-stage renal disease and require renal replacement therapy.
Transplantation Proceedings | 2012
Ciro Esposito; C. Migotto; Massimo Torreggiani; N. Maggi; Alessandra Manini; F. Castoldi; Fabrizio Grosjean; Filippo Mangione; Massimo Abelli; Maria Lucia Scaramuzzi; Davide Catucci; A. Dal Canton
Although many variables may affect long-term graft survival no biomarker is available to identify donor kidney with poor quality and with inadequate short and long-term outcome. While in marginal donors pre-transplant renal biopsies are commonly performed to establish if donor kidneys are suitable for transplantation they are not performed in standard donors. In this study we assessed the relevance of pre-transplant morphological features on post-transplant renal function and evaluated the association between perioperative parameters with posttransplant histological and clinical findings. Kidney transplant recipients undergone pre-transplant and post transplant protocol biopsies at 1, 6, and 12 months were enrolled in the study. Perioperative and posttransplant clinical and biochemical parameters were recorded. Semiquantitative analysis of PAS stained kidney sections was used to determine the degree of lesions. Glomerular volume was measured by computed morphometry. A strong inverse correlation was found between donor age and renal graft function at 1, 6, and 12 months after transplantation. A prompt functional recovery was associated with a better renal function at 6 months and one year. Kidneys with higher glomerular volume demonstrated a lower serum creatinine at 1 month. Higher tubulo-interstitial grading at protocol biopsies was associated with a poor renal function at 1 month. Our findings confirm the importance of donor age in kidney transplant long-term outcome and demonstrate that pretransplant and protocol biopsies are valid options to determine graft outcome and to define therapeutic strategies and tailor immunosuppressive regimen for each patient.
BMC Nephrology | 2018
Vittoria Esposito; Giulia Mazzon; Paola Baiardi; Massimo Torreggiani; Luca Semeraro; Davide Catucci; Marco Colucci; Alice Mariotto; Fabrizio Grosjean; Giacomo Bovio; Ciro Esposito
Nephrology Dialysis Transplantation | 2018
Giuseppe Sileno; Alice Guerini; Massimo Torreggiani; Marco Colucci; Grazia Bonelli; Davide Catucci; Vittoria Esposito; Alice Mariotto; Ciro Esposito
Nephrology Dialysis Transplantation | 2017
Massimo Torreggiani; Grazia Bonelli; Alice Mariotto; Marco Colucci; Vittoria Esposito; Davide Catucci; Luca Semeraro; Laura Villani; Ciro Esposito
Nephrology Dialysis Transplantation | 2017
Marco Colucci; Massimo Torreggiani; Giuseppe Sileno; Vittoria Esposito; Davide Catucci; Alice Mariotto; Grazia Bonelli; Gabriella Adamo; Luca Semeraro; Giovanni Montagna; Emanuela Efficace; Fabrizio Calliada; Ciro Esposito
Nephrology Dialysis Transplantation | 2016
Massimo Torreggiani; Lorenzo Cianfanelli; Marco Colucci; Vittoria Esposito; Davide Catucci; Luca Semeraro; Fabrizio Grosjean; Antonio Dal Canton; Giovanni Palladini; Giampaolo Merlini; Ciro Esposito
Nephrology Dialysis Transplantation | 2016
Massimo Torreggiani; Micaela Gentile; Marco Colucci; Maria Adelaide Garlando; Vittoria Esposito; Davide Catucci; Giovanni Montagna; Luca Semeraro; Ciro Esposito
Nephrology Dialysis Transplantation | 2016
Vittoria Esposito; Maria Adelaide Garlando; Davide Catucci; Marco Colucci; Massimo Torreggiani; Anna Amelia Colombo; Emilio Paolo Alessandrino; Ciro Esposito